Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery

Adam C Salisbury1, J Aaron Grantham1, W Morris Brown2

  • 1Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City, Kansas City, Missouri, USA.

Insights

Patients ineligible for coronary artery bypass grafting (CABG) undergoing percutaneous coronary intervention (PCI) have complex conditions. PCI leads to improved health status and mortality rates lower than surgeon estimates.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Outcomes

Background:

  • Percutaneous coronary intervention (PCI) is increasingly utilized for patients unsuitable for coronary artery bypass grafting (CABG).
  • Limited data exists on the characteristics and outcomes of this specific patient cohort.
  • Complex coronary artery disease (CAD) necessitates alternative revascularization strategies.

Purpose of the Study:

  • To characterize patients with left main or multivessel CAD who are ineligible for CABG.
  • To evaluate the accuracy of risk prediction models in this population.
  • To assess the clinical outcomes and health status following PCI.

Main Methods:

  • Prospective registry of patients undergoing medical therapy + PCI for complex CAD.
  • Independent core laboratory analysis of angiograms.
  • Calculation of observed-to-expected 30-day mortality ratios using STS, EuroSCORE II, surgeon estimates, and NCDR CathPCI models.
  • Assessment of patient health status at baseline, 1 month, and 6 months.

Main Results:

  • 726 patients were enrolled with a mean SYNTAX score of 32.4 ± 12.2 (pre-PCI).
  • All-cause mortality was 5.6% at 30 days and 12.3% at 6 months.
  • Observed-to-expected mortality ratios varied significantly by risk model: STS (1.06), EuroSCORE II (0.99), surgeon estimates (0.59), and NCDR CathPCI (4.46).
  • Significant improvements in SAQ and Kansas City Cardiomyopathy Questionnaire scores were observed by 6 months.

Conclusions:

  • Patients ineligible for CABG undergoing PCI present with complex clinical profiles and high disease burden.
  • Post-PCI mortality is lower than surgeon estimates and similar to surgical risk models, but significantly higher than NCDR CathPCI predictions.
  • PCI improves patients' health status significantly up to 6 months post-procedure.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
20
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
17
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
13